Zealand acquires a struggling diabetes med-tech in push into US market
Zealand Pharma is expanding again.
Four months after buying out Canada’s Encycle Therapeutics and their library of GI-drugging peptides, Zealand has agreed to purchase …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.